G-CSF treatment in decompensated liver disease: a double-edged sword? Cornelius EngelmannThomas Berg Editorial Open access 02 September 2022 Pages: 979 - 982
Management of spontaneous portosystemic shunts at the time of liver transplantation: treatment or observation? Results of a systematic review Caterina CusumanoStefano GussagoPietro Addeo Review Article 08 August 2022 Pages: 983 - 992
Liver transplantation in patients with acute-on-chronic liver failure Gandhi LankeJoseph J. AlukalPaul J. Thuluvath Review Article 29 July 2022 Pages: 993 - 1000
Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5 Chen-Hua LiuJia-Horng Kao Review Article 25 July 2022 Pages: 1001 - 1019
Direct antiviral therapy for hepatitis C cirrhotic patients in liver transplantation settings: a systematic review Jonathan LiVivian WuCalvin Q. Pan Review Article 09 September 2022 Pages: 1020 - 1031
MAFLD, patient-centred care, and APASL Shiv K. SarinMohammed EslamMasao Omata Point-of-View 07 September 2022 Pages: 1032 - 1034
Non-invasive evaluation of NAFLD and the contribution of genes: an MRI-PDFF-based cross-sectional study Aruhan YangXiaoxue ZhuGuoyue Lv Original Article 12 July 2022 Pages: 1035 - 1051
Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver disease Yuanyuan KongTingting Lvthe BAVENO Cooperation: an EASL consortium Original Article 09 September 2022 Pages: 1052 - 1063
The regulation effect of GLUT9/SLC2A9 on intrahepatic uric acid level and metabolic associated fatty liver disease Hang ZengChenxi TangChaohui Yu Original Article 25 August 2022 Pages: 1064 - 1074
CT-based visual grading system for assessment of hepatic steatosis: diagnostic performance and interobserver agreement Hyo Jung ParkKyoung Won KimSung-Gyu Lee Original Article 05 July 2022 Pages: 1075 - 1084
Low skeletal muscle mass is associated with more severe histological features of non-alcoholic fatty liver disease in male Xiao-Yan PanWen-Yue LiuMing-Hua Zheng Original Article 13 July 2022 Pages: 1085 - 1093
Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort study Natassia TanN. Nguthe Melbourne Liver Group Original Article Open access 03 June 2022 Pages: 1094 - 1104
ABC: a novel algorithm to stratify decompensation risk in patients with compensated advanced chronic liver disease (CHESS2108): an international, multicenter cohort study Chuan LiuJia LiXiaolong Qi Original Article 24 May 2022 Pages: 1105 - 1115
Low platelets: a new and simple prognostic marker for patients with hepatitis E virus-related acute liver failure Xiuying MuJun ZouFu-Sheng Wang Original Article 28 February 2022 Pages: 1116 - 1126
Multiple cycles of granulocyte colony-stimulating factor in decompensated cirrhosis: a double-blind RCT Aswath VenkitaramanArka DeVirendra Singh Original Article 23 March 2022 Pages: 1127 - 1136
The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma Nai-Jung ChiangYa-Chin HouYan-Shen Shan Original Article 03 July 2022 Pages: 1137 - 1149
Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study Takeshi HatanakaSatoru KakizakiOn behalf of the Real-life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan) Original Article 24 June 2022 Pages: 1150 - 1160
Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain José-Manuel Ramos-RinconHéctor Pinargote-CelorioVicente Soriano Original Article 06 June 2022 Pages: 1161 - 1169
Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study Kurvi PatwalaDavid Stephen PrinceAnouk Dev Original Article Open access 25 August 2022 Pages: 1170 - 1178
Combining stereotactic body radiotherapy with camrelizumab for unresectable hepatocellular carcinoma: a single-arm trial Jian-Xu LiTing-Shi SuBang-De Xiang Original Article Open access 24 August 2022 Pages: 1179 - 1187
A deep learning model with incorporation of microvascular invasion area as a factor in predicting prognosis of hepatocellular carcinoma after R0 hepatectomy Kang WangYanjun XiangShuqun Cheng Original Article 24 August 2022 Pages: 1188 - 1198
Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment Ching-Tso ChenYin-Hsun FengYu-Yun Shao Original Article 20 August 2022 Pages: 1199 - 1207
Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter study Ke SuYanlin LiuYunwei Han Original Article Open access 16 August 2022 Pages: 1208 - 1219
A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma Chuan JinJian-Sen ZhaoYe Song Original Article 10 August 2022 Pages: 1220 - 1233
Acute variceal bleeding portends poor outcomes in patients with acute-on-chronic liver failure: a propensity score matched study from the APASL ACLF Research Consortium (AARC) Sanchit SharmaSamagra AgarwalAPASL ACLF Research Consortium (AARC) for APASL ACLF Working Party Original Article 18 July 2022 Pages: 1234 - 1243
Aspirin for patients after TIPS: an old dog with new tricks? Jitao WangDengxiang LiuXiaolong Qi Letter to the Editor 29 June 2022 Pages: 1244 - 1245
Response to: Aspirin for patients after TIPS. An old dog with new tricks? Leon Louis SeifertPhilipp SchindlerHauke Heinzow Letter to the Editor Open access 29 July 2022 Pages: 1246 - 1247
Letter to the editor: Treating portal vein thrombosis in cirrhosis: is anticoagulation therapy overestimated? Xiaobing WangLiping Chen Letter to the Editor 18 August 2022 Pages: 1248 - 1249
Is laparoscopic hepatectomy superior to laparotomic hepatectomy? The debate continues Yitao ZhengXiaming HuangHongqi Shi Letter to the Editor 25 August 2022 Pages: 1250 - 1251